An influential not-for-profit group has issued a draft framework for how next-generation sequencing tests for oncology care should be reimbursed by payers. The report from The Center for Medical Technology (CMPT) comes at a time when anxiety regarding the rates of reimbursement for molecular- based tests has been running high. Many of the regional fiscal…
CMTP Issues Draft Framework for Covering NGS Testing
An influential not-for-profit group has issued a draft framework for how next-generation sequencing tests for oncology care should be reimbursed by payers. The report from The Center for Medical Technology (CMPT) comes at a time when anxiety regarding the rates of reimbursement for molecular- based tests has been running high. Many of the regional fiscal […]